Skip to content

Blog Articles

  • Risk and Compliance Solutions — What You Need to Know

    September 6, 2023

    As the payments landscape evolves toward faster and more seamless onboarding, businesses are faced with an increasing need to integrate better risk and compliance solutions throughout the lifecycle of their merchants. In this post, we explore what risk and compliance solutions are, and delve into the benefits of LegitScript Merchant Monitoring.

  • LegitScript Celebrates National Recovery Month — Here’s Why

    September 6, 2023

    In service of LegitScript’s mission of furthering safety and transparency for the commercial internet, we join the recovery community in celebrating Recovery Month this September. Read further to understand the ‘why’ and ‘how’ behind LegitScript’s support. Then, apply for our Addiction Treatment Certification during National Recovery Month and save $2,500.

  • Problematic Products Spotlight: Amanita muscaria

    August 11, 2023

    LegitScript analysts uncovered the problematic product Amanita muscaria during their monitoring work. Read further to understand why it’s problematic, and how it differs from another more common psychedelic drug.

  • Some Medical Spas Are Offering These Unapproved Treatments

    August 4, 2023

    Medical spas are increasingly popular for the variety of services they offer, but they sometimes violate federal laws established to protect consumers. Read further to understand what a med spa is, and how some spas use unapproved drugs to treat their patients.

  • What Are Nootropics and Why Are They Problematic?

    July 28, 2023

    Nootropics — when used properly — improve cognitive function. What happens when they’re misused by healthy individuals? Read further to understand what nootropic products are, and what makes them problematic. Then, download our comprehensive Nootropics FAQ.

  • These 3 Factors Contributed to the Rise of Synthetic Identity Fraud

    July 21, 2023

    Synthetic Identity Fraud is a blend of genuine and false data bad actors use to gain unauthorized access to financial services like credit, loans, and merchant accounts. Read further to understand the unintended consequences of automation, randomization of social security numbers, and large-scale data breaches. Then, download our 20-page introductory guide on Synthetic Identity Fraud.

  • We Took A Deep Dive Into Weapons — Here’s What We Found

    July 7, 2023

    In LegitScript’s most recent webinar, we took a deep dive into the regulatory history and current landscape of online weapons sales. Read further for a snapshot of the political climate surrounding the proposal to implement a new merchant category code (MCC) for firearms. Then, dive into our three-part Deep Dive Webinar Series.

  • Disaster Struck Turkey and Syria — and Bad Actors Took Advantage

    June 29, 2023

    by Wei Yu

    In February 2023, both Turkey and Syria were hit with a massive earthquake — and bad actors capitalized on the flood of donations pouring into the countries. Read further for more details about how charity scams work, and how LegitScript’s monitoring solutions protect companies like yours.

  • What You Need to Know About the INFORM Consumers Act

    June 22, 2023

    The INFORM Consumers Act goes into effect June 27, 2023, and the Federal Trade Commission (FTC) recently sent letters to 50 online marketplaces in preparation. Read further for more information about what the INFORM Consumers Act is and what it means for online marketplaces. Then contact us for more information about how LegitScript can help.

  • What You Need To Know About The Visa Integrity Risk Program (VIRP)

    June 13, 2023

    Visa’s compliance program addressing the reputational risk and potential brand damage associated with acquiring merchants in high-risk verticals or industries, the Visa Global Brand Protection Program (GBPP), is being replaced by the Visa Integrity Risk Program (VIRP).

  • What Is Semaglutide and Why Is it Problematic?

    May 26, 2023

    The FDA approved the drug semaglutide for those suffering from obesity, diabetes, and other weight-related illnesses. Since its approval, semaglutide has faced worldwide popularity — resulting in supply shortages.

  • The FDA Warns Consumers About Apetamin — Here’s Why

    May 17, 2023

    The US Food and Drug Administration (FDA) recently warned the public about online sales of Apetamin — an unapproved drug produced internationally and sold worldwide. Read more to understand why this drug is potentially harmful to consumers.

  • Why Transparent Labeling Is Important in CBD Manufacturing

    May 11, 2023

    LegitScript vets CBD manufacturer’s products for accurate and transparent labeling in line with regulatory bodies like the US Food and Drug Administration (FDA). Read further to understand what LegitScript’s CBD Certification does to protect consumers.

  • We Took a Deep Dive Into Vaping and Tobacco — Here’s What We Found

    May 4, 2023

    LegitScript’s Associate General Counsel, Gerard Olson, dives deep into the regulatory landscape of vaping and tobacco in our Deep Dive Webinar Series. Read this recap of the webinar to understand who regulates tobacco and vaping products, and what it takes to get a tobacco product to market. Then, watch the full webinar at the button below.

  • 4 High-Growth Industries That Can Help You Build Revenue

    April 13, 2023

    The payments space is competitive, with new payment facilitators and ISOs entering the fray every year. Rather than merely capturing new merchants or peeling ones away from competitors, many payments companies are looking at new markets to help build revenue in ways that are conscientious and compliant. Keep reading to learn about rapidly growing industries to consider.